Growth Metrics

Innoviva (INVA) Equity Average (2016 - 2026)

Innoviva filings provide 15 years of Equity Average readings, the most recent being $1.1 billion for Q4 2025.

  • On a quarterly basis, Equity Average rose 60.53% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 60.53% increase, with the full-year FY2025 number at $1.1 billion, up 60.53% from a year prior.
  • Equity Average hit $1.1 billion in Q4 2025 for Innoviva, up from $862.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.1 billion in Q4 2025 to a low of $442.8 million in Q3 2021.
  • Median Equity Average over the past 5 years was $627.4 million (2022), compared with a mean of $642.1 million.
  • Biggest five-year swings in Equity Average: surged 74.4% in 2021 and later dropped 17.35% in 2022.
  • Innoviva's Equity Average stood at $508.9 million in 2021, then grew by 18.61% to $603.6 million in 2022, then rose by 7.89% to $651.2 million in 2023, then grew by 4.4% to $679.9 million in 2024, then skyrocketed by 60.53% to $1.1 billion in 2025.
  • The last three reported values for Equity Average were $1.1 billion (Q4 2025), $862.4 million (Q3 2025), and $680.9 million (Q2 2025) per Business Quant data.